Pyxis Oncology, Inc. (PYXS)
1.645
-0.04
(-2.66%)
USD |
NASDAQ |
Nov 03, 14:23
Pyxis Oncology Price to Book Value : 9.122 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 9.371 |
| October 30, 2026 | 10.04 |
| October 29, 2026 | 10.48 |
| October 28, 2026 | 10.98 |
| October 27, 2026 | 10.20 |
| October 26, 2026 | 9.371 |
| October 23, 2026 | 9.316 |
| October 22, 2026 | 9.482 |
| October 21, 2026 | 9.759 |
| October 20, 2026 | 10.20 |
| October 19, 2026 | 9.759 |
| October 16, 2026 | 9.316 |
| October 15, 2026 | 9.981 |
| October 14, 2026 | 9.926 |
| October 13, 2026 | 10.26 |
| October 12, 2026 | 11.15 |
| October 09, 2026 | 11.26 |
| October 08, 2026 | 11.03 |
| October 07, 2026 | 11.15 |
| October 06, 2026 | 11.20 |
| October 05, 2026 | 12.42 |
| October 02, 2026 | 11.87 |
| October 01, 2026 | 12.14 |
| September 30, 2026 | 12.92 |
| September 29, 2026 | 16.08 |
| Date | Value |
|---|---|
| September 28, 2026 | 16.08 |
| September 25, 2026 | 15.86 |
| September 24, 2026 | 16.19 |
| September 23, 2026 | 17.86 |
| September 22, 2026 | 18.60 |
| September 21, 2026 | 17.69 |
| September 18, 2026 | 18.46 |
| September 17, 2026 | 18.91 |
| September 16, 2026 | 18.52 |
| September 15, 2026 | 18.46 |
| September 14, 2026 | 19.02 |
| September 11, 2026 | 17.80 |
| September 10, 2026 | 18.13 |
| September 09, 2026 | 18.74 |
| September 08, 2026 | 21.57 |
| September 04, 2026 | 21.57 |
| September 03, 2026 | 19.77 |
| September 02, 2026 | 20.79 |
| September 01, 2026 | 19.08 |
| August 31, 2026 | 17.97 |
| August 28, 2026 | 17.91 |
| August 27, 2026 | 18.41 |
| August 26, 2026 | 18.52 |
| August 25, 2026 | 16.97 |
| August 24, 2026 | 16.41 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cypherpunk Technologies, Inc. | 1.996 |
| Cue Biopharma, Inc. | 44.66 |
| Yarrow Bioscience, Inc. | 0.5151 |
| Faeth Therapeutics, Inc. | 2.949 |
| Indaptus Therapeutics, Inc. | 38.55 |
Price to Book Value Related Metrics
| PS Ratio | 9.415 |
| Price | 1.645 |
| Earnings Yield | -85.31% |
| Market Cap | 104.35M |